Apellis Pharmaceuticals (NASDAQ: APLS) is preparing to release its quarterly earnings on Thursday, 2025-10-30. Here's a brief overview of what investors should keep in mind before the announcement.

The lesion characteristics of patients with geographic atrophy (GA) were found to affect the lesion growth rate, with ...

“There are not enough judges to meet the demands of the number of cases in the system,” said Ontario Superior Court Chief ...

Inflammation is a critical component of the immune response that plays a pivotal role in maintaining tissue homeostasis.

Activation of the complement cascade of proteases has been linked to autoimmune and kidney diseases, including systemic lupus ...

Every day, your immune system performs a delicate balancing act, attacking harmful invaders while protecting your own tissues ...

Ottawa removed most of its diplomats from India in October 2023 after New Delhi threatened to strip diplomatic immunity from 41 Canadian officials and their 42 dependants.

Learn about the innovative plug flow technology that could make rain a major renewable energy source for cities worldwide.

Neil Bressler, M.D., a professor of ophthalmology at Johns Hopkins and editor-in-chief of JAMA Ophthalmology, argued that complement inhibition for geographic atrophy is a game changer. His debating ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, ...